A Parallel Group, Double-Blind, Randomized, PlaceboControlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing an Acute Attack of Migraine

  • STATUS
    Not Recruiting
Updated on 16 August 2022

Summary

To evaluate the effect of eptinezumab compared to placebo with respect to time to headache pain freedom AND time to absence of most bothersome symptom during an intercurrent migraine that occurs in subjects who are candidates for preventive therapy.
 

Details
Condition Migraine (Adult)
Clinical Study IdentifierTX229386
Last Modified on16 August 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note